Similarly, patients with pancreatic cancer with high MARCO expression in tumor tissues had a shorter DFS (3.0 months vs 15.5 months, P = 0.0004) and OS (13.0 months vs 24.0 months, P = 0.0003) than MARCO low patients (Figures 7C, D). The gene discussed is MARCO; the disease is familial pancreatic carcinoma.